This NCCIH grant is for the continuation or revision of Clinical Coordinating Centers (CCCs) supporting ongoing multisite clinical trials. It aims to fund competing renewals when additional time is needed to complete trials or for extended follow-up to assess long-term outcomes. Competitive revisions are also supported for adding ancillary studies to existing NCCIH-supported clinical trials with compelling justification. The CCC’s role is crucial for providing scientific rationale, operational planning, project management, participant recruitment/retention, scientific conduct, and results dissemination. Applicants planning a renewal or revision are strongly encouraged to contact the relevant Scientific/Research contact before applying.
Opportunity ID: 331258
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-117 |
| Funding Opportunity Title: | Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.213 — Research and Training in Complementary and Integrative Health |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 01, 2021 |
| Last Updated Date: | Feb 01, 2021 |
| Original Closing Date for Applications: | Sep 27, 2023 |
| Current Closing Date for Applications: | Sep 27, 2023 |
| Archive Date: | Nov 02, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education State governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Small businesses For profit organizations other than small businesses County governments Special district governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages applications for competing renewal of Clinical Coordinating Center (CCC) for ongoing clinical trials supported by NCCIH; or competitive revisions to support ancillary studies to ongoing NCCIH supported clinical trials. Extension of an ongoing clinical trial will be supported when there is need for additional time to complete the trial or when an extended period of follow up is well justified to assess longer term outcomes. Competitive revisions will be supported when there is compelling justification for the addition of an ancillary study to an ongoing clinical trial. The objective of the Clinical Coordinating Center is to provide the design scientific rationale and a comprehensive scientific and operational plan for the clinical trial. The Clinical Coordinating Center is expected to be responsible for project management, participant recruitment and retention strategies, performance milestones, scientific conduct, and dissemination of results. Both a DCC application and a corresponding Clinical Coordinating Center application should be submitted simultaneously for consideration by NCCIH if both are needed to complete the ongoing clinical trial. Applicants are strongly encouraged to contact the appropriate Scientific/Research contact for the ongoing clinical trial for which they are planning a competing renewal application or competitive revision prior to submitting to this FOA. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-117.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 331258 Full Announcement-PAR-21-117 -> PAR-21-117-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00265266 | Feb 15, 2021 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270470 | Nov 18, 2021 | Jan 24, 2023 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278430 | Nov 15, 2022 | Sep 27, 2023 | View |
Package 1
Mandatory forms
331258 RR_SF424_2_0-2.0.pdf
331258 PHS398_CoverPageSupplement_5_0-5.0.pdf
331258 RR_OtherProjectInfo_1_4-1.4.pdf
331258 PerformanceSite_2_0-2.0.pdf
331258 RR_KeyPersonExpanded_2_0-2.0.pdf
331258 RR_Budget_1_4-1.4.pdf
331258 PHS398_ResearchPlan_4_0-4.0.pdf
331258 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
331258 RR_SubawardBudget30_1_4-1.4.pdf
331258 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
331258 RR_SF424_5_0-5.0.pdf
331258 PHS398_CoverPageSupplement_5_0-5.0.pdf
331258 RR_OtherProjectInfo_1_4-1.4.pdf
331258 PerformanceSite_4_0-4.0.pdf
331258 RR_KeyPersonExpanded_4_0-4.0.pdf
331258 RR_Budget_3_0-3.0.pdf
331258 PHS398_ResearchPlan_4_0-4.0.pdf
331258 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
331258 RR_SubawardBudget30_3_0-3.0.pdf
331258 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
331258 RR_SF424_5_0-5.0.pdf
331258 PHS398_CoverPageSupplement_5_0-5.0.pdf
331258 RR_OtherProjectInfo_1_4-1.4.pdf
331258 PerformanceSite_4_0-4.0.pdf
331258 RR_KeyPersonExpanded_4_0-4.0.pdf
331258 RR_Budget_3_0-3.0.pdf
331258 PHS398_ResearchPlan_5_0-5.0.pdf
331258 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
331258 RR_SubawardBudget30_3_0-3.0.pdf
331258 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
